GENERAL ATLANTIC, L.P.

PrivateCIK: 1017645
Location

NEW YORK, NY

πŸ“‹ What this filing means

GENERAL ATLANTIC, L.P. filed this quarterly 13F‑HR report disclosing 18 equity positions with a total reported market value of $3.52B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

18
Positions
$3.52B
Total AUM (reported)
251.08M
Total Shares

Allocation by class

TOTAL AUM$3.52B18 positions
COM$1.55B44.2%
CL A$1.10B31.2%
CL A COM$601.67M17.1%
SPONSORED ADS$154.81M4.4%
SHS CL A$67.62M1.9%
ADS$39.86M1.1%

Portfolio Concentration

Top 350.1%4–1045.1%11–254.7%TOP 1095.3%0%100%
Top 3$1.76B50.1%
4–10$1.59B45.1%
11–25$166.41M4.7%

Top 3 weight

50.1%

Top 10 weight

95.3%

Voting Authority Distribution

Total shares with voting rights: 251.08M

Sole

Full voting authority

251.08M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole18
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings18
Rows:

ALIGNMENT HEALTHCARE

SOLE
COM
Shares60.99M
TypeSH
Market value$720.94M
20.50%
Sole
60.99M
Shared
0.00
None
0.00

XP, INC

SOLE
CL A
Shares29.62M
TypeSH
Market value$531.34M
15.11%
Sole
29.62M
Shared
0.00
None
0.00

DLOCAL

SOLE
CL A COM
Shares63.91M
TypeSH
Market value$511.25M
14.53%
Sole
63.91M
Shared
0.00
None
0.00

SQUARESPACE

SOLE
CL A
Shares10.61M
TypeSH
Market value$492.67M
14.01%
Sole
10.61M
Shared
0.00
None
0.00

ALKAMI

SOLE
COM
Shares15.52M
TypeSH
Market value$489.51M
13.92%
Sole
15.52M
Shared
0.00
None
0.00

CENTESSA PHARMACEUTICALS

SOLE
Sponsored ADS
Shares9.68M
TypeSH
Market value$154.81M
4.40%
Sole
9.68M
Shared
0.00
None
0.00

AKERO THERAPEUTICS

SOLE
COM
Shares5.23M
TypeSH
Market value$150.16M
4.27%
Sole
5.23M
Shared
0.00
None
0.00

PHARVARIS

SOLE
COM
Shares7.53M
TypeSH
Market value$139.48M
3.97%
Sole
7.53M
Shared
0.00
None
0.00

EUROPEAN WAX CENTER

SOLE
CL A COM
Shares13.11M
TypeSH
Market value$89.15M
2.53%
Sole
13.11M
Shared
0.00
None
0.00

BLEND LABS

SOLE
CL A
Shares19.13M
TypeSH
Market value$71.75M
2.04%
Sole
19.13M
Shared
0.00
None
0.00

ROYALTY PHARMA

SOLE
SHS CL A
Shares1.50M
TypeSH
Market value$42.44M
1.21%
Sole
1.50M
Shared
0.00
None
0.00

THIRD HARMONIC BIO

SOLE
COM
Shares2.96M
TypeSH
Market value$40.09M
1.14%
Sole
2.96M
Shared
0.00
None
0.00

IMMUNOCORE

SOLE
ADS
Shares1.26M
TypeSH
Market value$39.28M
1.12%
Sole
1.26M
Shared
0.00
None
0.00

RISKIFIED

SOLE
SHS CL A
Shares5.32M
TypeSH
Market value$25.19M
0.72%
Sole
5.32M
Shared
0.00
None
0.00

ACELYRIN

SOLE
COM
Shares2.89M
TypeSH
Market value$14.25M
0.41%
Sole
2.89M
Shared
0.00
None
0.00

WISH

SOLE
CL A
Shares609.62K
TypeSH
Market value$3.32M
0.09%
Sole
609.62K
Shared
0.00
None
0.00

GROVE COLLABORATIVE

SOLE
CL A COM
Shares936.02K
TypeSH
Market value$1.26M
0.04%
Sole
936.02K
Shared
0.00
None
0.00

ADAGENE

SOLE
ADS
Shares264K
TypeSH
Market value$586.1K
0.02%
Sole
264K
Shared
0.00
None
0.00
GENERAL ATLANTIC, L.P. 13F Holdings β€” 18 Positions | Finecho